With an overall 12 years’ in-depth collaborations in medical/cancer/public health research, Dr. Liu holds over 160 peer-reviewed publications and served as a lead biostatistician in variety grant proposals (e.g., R01, P01, SPORE, U54). She has a broad spectrum of experiences and expertises in cancer research, such as cancer outcome research based on national cancer registry databases, Causal inference based on observational studies, cancer risk stratification and validation, dynamic prognostic biomarker development for early cancer diagnosis, optimal treatment region, and phase I and II clinical trial design. She determines to bridge the statistical innovation to clinical research, to promote high standards in research with quality and efficiency in collaboration, and to challenge students to gain real-life skills and to be independent. She also initiated an efficient collaborative framework and analytic workflow for NCDB related collaboration and created a sequential high-performance SAS macro for streamlined data analysis. Dr. Liu is currently served as the Biostatistics and Bioinformatics Core director for Emory Lung P01.